» Articles » PMID: 26614725

Managing Neuropathic Pain

Overview
Specialty General Medicine
Date 2015 Nov 29
PMID 26614725
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Neuropathic pain (NP) arises from injuries or diseases affecting the somatosensory component of the nervous system at any level of the peripheral or central nervous system. NP is diagnosed based on common neurologic signs and symptoms. NP is best treated with a combination of multiple therapeutic approaches, and treatments include conservative, complementary, medical, interventional, and surgical treatment modalities. Goals of treatment are the same as in pain management and include improvement in pain control and in coping skills as well as restoration of functional status. Most patients with NP benefit most from an individualized, multimodal approach that emphasizes both pain and function.

Citing Articles

Bedside Neuromodulation of Persistent Pain and Allodynia with Caloric Vestibular Stimulation.

Ngo T, Barsdell W, Law P, Arnold C, Chou M, Nunn A Biomedicines. 2024; 12(10).

PMID: 39457677 PMC: 11505407. DOI: 10.3390/biomedicines12102365.


Diabetic peripheral neuropathy and neuromodulation techniques: a systematic review of progress and prospects.

Mittal R, McKenna K, Keith G, McKenna E, Lemos J, Mittal J Neural Regen Res. 2024; 20(8):2218-2230.

PMID: 39359078 PMC: 11759018. DOI: 10.4103/NRR.NRR-D-24-00270.


Synergic Effect of Early Administration of Probiotics and Adipose-Derived Mesenchymal Stem Cells on Alleviating Inflammation-Induced Chronic Neuropathic Pain in Rodents.

Chen K, Lin H, Li Y, Sung P, Chen Y, Yin T Int J Mol Sci. 2022; 23(19).

PMID: 36233275 PMC: 9570240. DOI: 10.3390/ijms231911974.


Peripheral Neuropathies Derived from COVID-19: New Perspectives for Treatment.

Cordova-Martinez A, Caballero-Garcia A, Perez-Valdecantos D, Roche E, Noriega-Gonzalez D Biomedicines. 2022; 10(5).

PMID: 35625788 PMC: 9138404. DOI: 10.3390/biomedicines10051051.


Post-concussion Syndrome Light Sensitivity: A Case Report and Review of the Literature.

Abusamak M, Alrawashdeh H Neuroophthalmology. 2022; 46(2):85-90.

PMID: 35273410 PMC: 8903744. DOI: 10.1080/01658107.2021.1983612.